What is GCAND's earnings per share (EPS)?

GCAND (GCAND) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

GCAND Financials

GCAND

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows GCAND (GCAND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GCAND FY2025 2026-04-22

GCAND's dominant visible mechanic is balance-sheet shrinkage, with obligations outlasting the operating asset base.

From FY2023 to FY2025, total assets collapsed from $172K to $815 while liabilities remained substantial, so the company became less able to absorb near-term claims even as the balance sheet got smaller. The key shift is liquidity erosion, not just negative equity: cash and current assets effectively disappeared faster than obligations did, leaving almost no working buffer.

FY2024 showed a smaller net loss than earlier years, but operating cash burn still hovered around -$103K to -$109K across FY2022-FY2024. That helps explain why cash still fell from $167K in FY2023 to $57K in FY2024 instead of stabilizing.

By FY2025, cash was only $815 against total liabilities of $742K, so the business appears funded mainly by obligations rather than by an asset cushion. The slightly less negative equity position than FY2024 is not a clean sign of operating improvement, because the asset base had nearly disappeared.

Financial Health Signals

Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of GCAND's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

GCAND's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$0.00

GCAND earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$815

YoY-98.6%

5Y CAGR-62.7%

GCAND held $815 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

944,935

YoY+76.1%

GCAND had 944,935 shares outstanding in fiscal year 2025. This represents an increase of 76.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GCAND Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	$13K-73.7%	$48K
Cost of Revenue	N/A	N/A	N/A	N/A	$13K-73.7%	$48K
Gross Profit	N/A	N/A	N/A	N/A	-$25+45.7%	-$46
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	-$156K+10.9%	-$175K+0.9%	-$177K+48.4%	-$343K-16.5%	-$294K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$179K+5.0%	-$188K+47.7%	-$360K+40.2%	-$602K	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	-$37K+22.5%	-$48K-10.8%	-$44K	N/A	-$40K-3.0%	-$39K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	-$36K	N/A	-$104K	N/A	-$46K-2.8%	-$45K
EPS (Diluted)	$0.00	N/A	$-0.04	$0.00	$0.00	N/A	$-0.09	$0.00

GCAND Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$815-98.6%	$58K-66.5%	$172K-38.6%	$280K-28.6%	$393K+118.2%	$180K
Current Assets	$815-98.6%	$57K-65.6%	$167K-38.2%	$270K-28.5%	$378K+136.4%	$160K
Cash & Equivalents	$815-98.6%	$57K-65.6%	$167K-38.2%	$270K-28.5%	$378K+234.2%	$113K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$742K-17.3%	$898K+7.7%	$834K+1.0%	$825K-4.3%	$862K+87.4%	$460K
Current Liabilities	$742K-17.3%	$898K+7.7%	$834K+1.0%	$825K-4.3%	$862K+87.4%	$460K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$742K+11.7%	-$840K-27.1%	-$661K-21.4%	-$545K-16.2%	-$469K-67.6%	-$280K
Retained Earnings	-$5.0M-7.1%	-$4.7M-4.0%	-$4.5M-4.4%	-$4.3M-9.2%	-$3.9M-18.1%	-$3.3M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1K+76.6%	$815-96.2%	$21K-20.1%	$27K-42.2%	$46K-20.0%	$58K-9.6%	$64K-23.2%	$83K
Current Assets	$1K+76.6%	$815-96.2%	$21K-20.1%	$27K-42.2%	$46K-19.4%	$57K-7.9%	$62K-22.5%	$80K
Cash & Equivalents	$1K+76.6%	$815-96.2%	$21K-20.1%	$27K-42.2%	$46K-19.4%	$57K-7.9%	$62K-22.5%	$80K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$776K+4.6%	$742K-34.3%	$1.1M+2.8%	$1.1M+26.3%	$870K-3.1%	$898K+4.3%	$861K+3.2%	$834K
Current Liabilities	$776K+4.6%	$742K-34.3%	$1.1M+2.8%	$1.1M	N/A	$898K+4.3%	$861K+3.2%	$834K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$775K-4.5%	-$742K+33.1%	-$1.1M-3.4%	-$1.1M-30.1%	-$824K+1.9%	-$840K-5.4%	-$797K-6.1%	-$751K
Retained Earnings	-$5.0M-0.7%	-$5.0M+6.3%	-$5.3M-0.7%	-$5.3M-8.0%	-$4.9M-5.2%	-$4.7M-0.9%	-$4.6M-1.0%	-$4.6M

GCAND Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$109K-6.1%	-$103K+4.0%	-$107K+54.3%	-$235K+18.7%	-$290K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	-$62K
Financing Cash Flow	$4K	N/A	N/A	N/A	$500K+13.7%	$440K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$4K	N/A	-$5K+72.5%	-$20K-74.8%	-$11K-127.0%	-$5K+72.8%	-$18K+63.2%	-$49K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$5K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GCAND Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	-0.2%-0.1pp	-0.1%
Operating Margin	N/A	N/A	N/A	N/A	-2716.9%-2104.0pp	-612.9%
Net Margin	N/A	N/A	N/A	N/A	-4768.2%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-309.8%-200.5pp	-109.4%+19.1pp	-128.5%+24.8pp	-153.3%	N/A
Current Ratio	0.00-0.1	0.06-0.1	0.20-0.1	0.33-0.1	0.44+0.1	0.35
Debt-to-Equity	-1.00+0.1	-1.07+0.2	-1.26+0.3	-1.51+0.3	-1.84-0.2	-1.64
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	-169.0%	N/A	-224.0%	N/A	-72.2%-18.2pp	-54.0%
Current Ratio	0.000.0	0.00-0.0	0.020.0	0.02	N/A	0.060.0	0.07-0.0	0.10
Debt-to-Equity	-1.000.0	-1.00+0.0	-1.020.0	-1.02	N/A	-1.07+0.0	-1.08+0.0	-1.11
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$742K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What are GCAND's total assets?

GCAND (GCAND) had $815 in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does GCAND have outstanding?

GCAND (GCAND) had 944,935 shares outstanding as of fiscal year 2025.

What is GCAND's current ratio?

GCAND (GCAND) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is GCAND's debt-to-equity ratio?

GCAND (GCAND) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is GCAND's debt-to-equity ratio negative or unusual?

GCAND (GCAND) has negative shareholder equity of -$742K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is GCAND?

GCAND (GCAND) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.